vs
Side-by-side financial comparison of GERON CORP (GERN) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $39.9M, roughly 1.2× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -39.0%, a 44.5% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -15.4%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs -6.4%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
GERN vs HHS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $39.9M |
| Net Profit | $-18.4M | $2.2M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | -0.3% |
| Net Margin | -39.0% | 5.5% |
| Revenue YoY | 67.1% | -15.4% |
| Net Profit YoY | 30.3% | — |
| EPS (diluted) | $-0.03 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $39.9M | ||
| Q3 25 | $47.2M | $39.5M | ||
| Q2 25 | $49.0M | $38.6M | ||
| Q1 25 | $39.6M | $41.6M | ||
| Q4 24 | — | $47.1M | ||
| Q3 24 | $28.3M | $47.6M | ||
| Q2 24 | $882.0K | $45.0M | ||
| Q1 24 | $304.0K | $45.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | $-18.4M | $-2.3M | ||
| Q2 25 | $-16.4M | $-335.0K | ||
| Q1 25 | $-19.8M | $-392.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.4M | $142.0K | ||
| Q2 24 | $-67.4M | $-27.8M | ||
| Q1 24 | $-55.4M | $-171.0K |
| Q4 25 | — | -0.3% | ||
| Q3 25 | -29.4% | 1.3% | ||
| Q2 25 | -25.4% | 0.1% | ||
| Q1 25 | -42.2% | -0.1% | ||
| Q4 24 | — | -3.3% | ||
| Q3 24 | -99.8% | 4.0% | ||
| Q2 24 | -7860.9% | 3.0% | ||
| Q1 24 | -18465.1% | 0.8% |
| Q4 25 | — | 5.5% | ||
| Q3 25 | -39.0% | -5.8% | ||
| Q2 25 | -33.4% | -0.9% | ||
| Q1 25 | -50.1% | -0.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -93.5% | 0.3% | ||
| Q2 24 | -7639.8% | -61.8% | ||
| Q1 24 | -18220.4% | -0.4% |
| Q4 25 | — | $0.30 | ||
| Q3 25 | $-0.03 | $-0.31 | ||
| Q2 25 | $-0.02 | $-0.05 | ||
| Q1 25 | $-0.03 | $-0.05 | ||
| Q4 24 | — | $-0.31 | ||
| Q3 24 | $-0.04 | $0.02 | ||
| Q2 24 | $-0.10 | $-3.84 | ||
| Q1 24 | $-0.09 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $20.5M |
| Total Assets | $567.4M | $91.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.6M | ||
| Q3 25 | $78.1M | $6.5M | ||
| Q2 25 | $77.7M | $4.8M | ||
| Q1 25 | $83.7M | $9.0M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $60.3M | $5.9M | ||
| Q2 24 | $116.9M | $11.0M | ||
| Q1 24 | $189.8M | $11.5M |
| Q4 25 | — | $20.5M | ||
| Q3 25 | $248.7M | $19.9M | ||
| Q2 25 | $259.5M | $22.2M | ||
| Q1 25 | $268.2M | $21.4M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $292.3M | $21.0M | ||
| Q2 24 | $306.7M | $20.6M | ||
| Q1 24 | $344.9M | $20.0M |
| Q4 25 | — | $91.8M | ||
| Q3 25 | $567.4M | $92.7M | ||
| Q2 25 | $555.2M | $95.0M | ||
| Q1 25 | $562.5M | $100.6M | ||
| Q4 24 | — | $101.8M | ||
| Q3 24 | $444.9M | $108.1M | ||
| Q2 24 | $449.4M | $109.7M | ||
| Q1 24 | $482.1M | $113.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $737.0K |
| Free Cash FlowOCF − Capex | — | $-686.0K |
| FCF MarginFCF / Revenue | — | -1.7% |
| Capex IntensityCapex / Revenue | — | 3.6% |
| Cash ConversionOCF / Net Profit | — | 0.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $737.0K | ||
| Q3 25 | $-13.6M | $3.2M | ||
| Q2 25 | $-27.4M | $-4.8M | ||
| Q1 25 | $-48.0M | $-818.0K | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $-58.9M | $-2.9M | ||
| Q2 24 | $-53.5M | $1.6M | ||
| Q1 24 | $-62.3M | $-5.7M |
| Q4 25 | — | $-686.0K | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $-5.1M | ||
| Q1 25 | — | $-923.0K | ||
| Q4 24 | — | $3.4M | ||
| Q3 24 | — | $-4.9M | ||
| Q2 24 | $-53.7M | $926.0K | ||
| Q1 24 | $-62.9M | $-6.2M |
| Q4 25 | — | -1.7% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | -13.1% | ||
| Q1 25 | — | -2.2% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | -10.2% | ||
| Q2 24 | -6086.6% | 2.1% | ||
| Q1 24 | -20680.3% | -13.7% |
| Q4 25 | — | 3.6% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 23.4% | 1.5% | ||
| Q1 24 | 202.3% | 1.2% |
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -20.76× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GERN
Segment breakdown not available.
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
